As previously reported, Guggenheim analyst Sandy Draper upgraded Accolade to Buy from Neutral with a $16 price target. r The firm’s benefits management survey highlighted Advocacy/Navigator benefits as an increasing area of focus and the company had a strong calendar 2022 selling season, demonstrated solid gross revenue retention, and indicated a faster than expected path to cash break even, the analyst tells investors in a research note. In addition, the firm recently hosted management for a series of investor meetings and came away with reinforced confidence, the analyst added.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ACCD:
- Accolade management to meet with Truist
- Accolade announces Michael Hilton to join board of directors
- Michael Hilton Joins Accolade Board of Directors
- Cathie Wood doubles down on these 2 small-cap stocks — here’s why you might want to ride her coattails
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
